Deerfield Management Discloses New Position in ANI Pharmaceuticals Inc (ANIP)

James E. Flynn‘s Deerfield Management reported a new stake in ANI Pharmaceuticals Inc (NASDAQ:ANIP). With nearly 660,000 shares in ANI, the fund now owns 5.85% of the company’s aggregate common stock outstanding, according to a recent 13G filing with the Securities and Exchange Commission.

ANI Pharmaceuticals

Incorporated in 11, 2001, ANI Pharmaceuticals Inc (NASDAQ:ANIP) is an emerging integrated specialty pharmaceutical company which develops, manufactures, and markets branded and generic prescription pharmaceuticals made in the US. The company also performs contract manufacturing for some of the largest pharmaceutical companies in the world. Last month, the company announced the closing of its seasoned public offering, in which it has issued 1.62 million shares of common stock, at a price of $31.00 per share, grossing $50.00 million of equity capital.

In its financial results for 2013, ANI highlighted that it reached record net revenues of $10.50 million in the fourth quarter of the year, generating $30.00 million revenues, but $0.92 net losses for the full last year. In 2014, the company is expected to perform significantly better, with consensus estimates settling around net profits of $1.30 per share. On average, analysts suggest that investors buy shares of ANI Pharmaceuticals Inc (NASDAQ:ANIP), setting a target price of $38.00 per share, compared to the current price of around $30.50.

Healthcare focused investment fund, Deerfield Management, owns an equity portfolio valued at nearly $2.00 billion and invested almost entirely (around 97.00%) in the Healthcare Sector. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) represents the largest share in the fund’s equity portfolio, the fund holding a position of more than 4.10 million shares in the company. Deerfield also owns large positions in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) and Array Biopharma Inc (NASDAQ:ARRY), with the respective amounts of 1.50 million and 11.25 million shares.

Earlier in April, Deerfield Management revealed a stake in the newly public Trivascular Technologies Inc (NASDAQ:TRIV), which started trading the same day. Shortly afterwards, the fund raised its position to 1.70 million shares from the previously held 632,700 shares of the company. Recently, Deerfield boosted its ownership of  Insmed Incorporated (NASDAQ:INSM) to 3.04 million shares - 7.75% of the company’s common stock.

Disclosure: none.

Recommended reading:

James Flynn, Deerfield Management Boost Stake in Streamline Health Solutions Inc. (STRM)

Sandell Asset Management Surges Stake in Meritor Inc (MTOR)

James Flynn, Deerfield Management Step Up Interest In Alphatec Holdings Inc (ATEC)

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!